The current status of recombinant human factor VIII.
Aronson
D L
DL
Division of Hematology/Oncology, George Washington University Medical Center, Washington, DC.
D005169:Factor VIII / Q000009:adverse effects / Q000627:therapeutic use*; D005544:Forecasting; D006467:Hemophilia A / Q000628:therapy*; D006801:Humans; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use*
D011994:Recombinant Proteins; D005169:Factor VIII